Canopy Growth Corporation (CGC) came out with a quarterly loss of $0.94 per share versus the Zacks Consensus Estimate of a loss of $0.10. This compares to loss of $0.28 per share a year ago.
Right now, cannabis companies are still reporting Q1 2025 earnings, and for most things, are looking good. It is undeniable how well the cannabis industry is doing, even as the road ahead is still a tough one. Profits are being made and growth is occurring throughout the sector.
Zacks.com users have recently been watching Canopy Growth (CGC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Canopy Growth Corporation (CGC) concluded the recent trading session at $1.64, signifying a -1.51% move from its prior day's close.
Canopy Growth Corporation (CGC) closed the most recent trading day at $1.44, moving -1.37% from the previous trading session.
The U.S. cannabis industry continues to surge, reaching an estimated $45 billion in 2025. Analysts expect it to grow to over $75 billion by 2030. With federal reform discussions advancing and legalization expanding, Canadian cannabis companies are positioning for growth. Many are making strategic moves to increase their U.S. exposure through acquisitions and partnerships.
Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
In the latest trading session, Canopy Growth Corporation (CGC) closed at $1.28, marking a +0.79% move from the previous day.
Canopy Growth (CGC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Canopy Growth (CGC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Recently, Zacks.com users have been paying close attention to Canopy Growth (CGC). This makes it worthwhile to examine what the stock has in store.
Investors are keeping a close eye on top Canadian cannabis stocks this week. These companies often benefit from strong U.S. market ties. Although cannabis remains federally illegal in the U.S., state-level markets continue to expand rapidly. As of early 2025, over 40 U.S. states have legalized cannabis. According to New Frontier Data, the U.S. cannabis industry could reach $72 billion by 2030. This growth potential keeps Canadian firms with U.S. exposure in focus. Recently, the U.S. Department of Health and Human Services recommended rescheduling cannabis to Schedule III. This sparked renewed optimism around federal reform.